Vascular nitric oxide resistance in type 2 diabetes
Cell Death & Disease · 11.07.2023 · 14 (7)
DOI: 10.1038/s41419-023-05935-5 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Cell Death & Disease, online erschienen am 11.07.2023. Verfasst von Zahra Bahadoran und 3 weiteren Autor:innen. Beteiligte Einrichtung: Nutrition and Endocrine Research Center, Research Institute for Endocrine Sciences, Shahid Beheshti University of Medical Sciences, Tehran, Iran. Hauptthemen laut MEDLINE: Nitric Oxide, Diabetes Mellitus, Type 2. Die Arbeit wurde bisher 79-mal zitiert (Crossref) und nennt 183 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Themen: Diabetes mellitus
Abstract (Originalsprache)
Vascular nitric oxide (NO•) resistance, manifested by an impaired vasodilator function of NO• in both the macro- and microvessels, is a common state in type 2 diabetes (T2D) associated with developing cardiovascular events and death. Here, we summarize experimental and human evidence of vascular NO• resistance in T2D and discuss its underlying mechanisms. Human studies indicate a ~ 13-94% decrease in the endothelium (ET)-dependent vascular smooth muscle (VSM) relaxation and a 6-42% reduced response to NO• donors, i.e., sodium nitroprusside (SNP) and glyceryl trinitrate (GTN), in patients with T2D. A decreased vascular NO• production, NO• inactivation, and impaired responsiveness of VSM to NO• [occurred due to quenching NO• activity, desensitization of its receptor soluble guanylate cyclase (sGC), and/or impairment of its downstream pathway, cyclic guanosine monophosphate (cGMP)-protein kinase G (PKG)] are the known mechanisms underlying the vascular NO• resistance in T2D. Hyperglycemia-induced overproduction of reactive oxygen species (ROS) and vascular insulin resistance are key players in this state. Therefore, upregulating vascular NO• availability, re-sensitizing or bypassing the non-responsive pathways to NO•, and targeting key vascular sources of ROS production may be clinically relevant pharmacological approaches to circumvent T2D-induced vascular NO• resistance.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- Nutrition and Endocrine Research Center, Research Institute for Endocrine Sciences, Shahid Beheshti University of Medical Sciences, Tehran, Iran.
- Department of Clinical Nutrition, Faculty of Nutrition Sciences and Food Technology, National Nutrition and Food Technology Research Institute, Shahid Beheshti University of Medical Sciences, Tehran, Iran.
- Department of Molecular, Cellular, and Biomedical Sciences, Sophie Davis School of Biomedical Education, City University of New York School of Medicine, New York, NY, 10031, USA.
- Endocrine Physiology Research Center, Research Institute for Endocrine Sciences, Shahid Beheshti University of Medical Sciences, Tehran, Iran. Ghasemi@endocrine.ac.ir.
ORCID-Profile: Asghar Ghasemi
Zitieren
APA
Bahadoran, Z., Mirmiran, P., Kashfi, K., & Ghasemi, A. (2023). Vascular nitric oxide resistance in type 2 diabetes. Cell Death & Disease, 14(7). https://doi.org/10.1038/s41419-023-05935-5
Vancouver
Bahadoran Z, Mirmiran P, Kashfi K, Ghasemi A. Vascular nitric oxide resistance in type 2 diabetes. Cell Death & Disease. 2023;14(7). doi:10.1038/s41419-023-05935-5
BibTeX
@article{Bahadoran2023,
author = {Bahadoran, Zahra and Mirmiran, Parvin and Kashfi, Khosrow and Ghasemi, Asghar},
title = {Vascular nitric oxide resistance in type 2 diabetes},
journal = {Cell Death & Disease},
year = {2023},
volume = {14},
number = {7},
doi = {10.1038/s41419-023-05935-5}
}
EUVIMED